The state Supreme Court has thrown out the appeal of a drug company seeking to overturn an $8.6 million punitive damages award in a hormone replacement therapy products liability case brought by a woman who developed breast cancer while taking Prempro.

In an order Monday, the justices dismissed as improvidently granted Wyeth Pharmaceuticals’ appeal in Daniel v. Wyeth Pharmaceuticals, determining allocatur never should have been granted in the case.